Market Survey on Gastro-retentive Drug Delivery Systems Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Gastro-retentive Drug Delivery Systems Market including High Density System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, and Floating Drug Delivery System Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Gastro-retentive Drug Delivery Systems Market Outlook (2023 to 2033)
Newly-released Gastro-retentive Drug Delivery Systems industry analysis report by Future Market Insights reveals that global sales of Gastro-retentive Drug Delivery Systems in 2022 were held at US$ 13.3 Billion. With a CAGR of 10.1% from 2023 to 2033, the market is expected to reach US$ 24.8 Billion by 2033. Floating Drug Delivery System is expected to be the highest revenue generating type, with a CAGR of 5% from 2023 to 2033.
Attribute
Details
Global Gastro-retentive Drug Delivery Systems Market (2023)
US$ 14 Billion
Global Gastro-retentive Drug Delivery Systems Market (2033)
US$ 24.8 Billion
Global Gastro-retentive Drug Delivery Systems Market CAGR (2023 to 2033)
10.1%
USA Gastro-retentive Drug Delivery Systems Market CAGR (2023 to 2033)
6%
Key Companies Profiled
F. Hoffmann La Roche
Glaxo Smith Kline
Lupin
Pfizer
Sun Pharma
Ranbaxy
Depomed
Galanix
Pharmacia
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Revenue of Gastro-retentive Drug Delivery Systems from 2018 to 2022 Compared to Demand Outlook for 2023 to 2033
As per the Gastro-retentive Drug Delivery Systems industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, market value of the Gastro-retentive Drug Delivery Systems industry increased at a CAGR of around 8.6%, wherein, countries such as the USA, China, Japan, United kingdom and South Korea held a significant share in the global market.
Rising disease burden throughout the world and the proven efficacy of GRDDS in addressing several gastric-related disorders such as gastric ulcers, and peptic ulcers, are some of the key reasons driving the market growth. Owing to this, the gastro-retentive Drug Delivery Systems market is projected to grow at a CAGR of 10.1% over the coming 10 years.
Manufacturing systems, formulation approaches, storage systems, and technologies involved in transporting a drug to its gastrointestinal target site make gastro-retentive drug delivery global sales. Medical professionals are making use of the principles of production, rental property, locality of prescription, metabolism, and toxicity to boost the safety and potency of a drug delivery system. By making use of a gastro-retentive delivery system, illnesses can be prevented and treated using nutrients.
Which factors are Driving the Gastro-retentive Drug Delivery Systems Market?
Large drug firms' investments to enhance gastro-retentive drug-delivery systems, along with the reduction in required doses due to enhanced bioavailability and an increase in the requirements for medications, have helped accelerate the market growth. The well-established efficacy of gastro-retentive drug delivery systems in treating a variety of stomach disorders such as peptic ulcer and gastric ulcer, as well as a growth in the incidence of H. Pylori infection, which can cause gastritis and gastric cancer, impart a significant impact on the market.
Gastro-retentive drug distribution technology has proven to be a useful way of regulating the administration of a wide range of medicinal substances while enhancing bioavailability. Advancements in controlled oral medication administration systems have been made in recent years because of technological advancements that overcome physical roadblocks such as unpredictable stomach emptying periods and short gastric residency times. By extending their dwell time in the upper GI tract, once-GRDDS can enhance oral bioavailability and therapeutic excellence.
Technological advancements for rate-controlled oral medication delivery systems are now overcoming physiological issues such as unexpected stomach emptying intervals and short gastric residency times. To address these issues, the gastro-retentive drug delivery system is designed for a longer stomach retention duration, which increases patient preference by extending the time available for medicine absorption.
Find your sweet spots for generating winning opportunities in this market.
Region-wise Analysis
Which Region is projected to Offer the Significant Opportunity for Gastro-retentive Drug Delivery Systems?
North America is expected to account for significant revenue in gastro-retentive drug delivery systems market, with a market projection of US$ 10 Billion. Regional expansion is expected to be facilitated by the introduction of improved gastro-retentive medication delivery technology and the implementation of novel treatment techniques in healthcare.
GRDDS are projected to be in high demand as the prevalence of gastrointestinal disorders grows in the United States and Canada, as they lengthen medication retention time in the stomach. Demand for these devices in the region is projected to be driven by the presence of a large patient pool. Rising research and development spending in emerging markets is expected to drive regional market expansion.
Country-wise Analysis
USA Gastro-retentive Drug Delivery Systems Market Analysis
Gastro-retentive Drug Delivery Systems Market in the US is expected to grow at a CAGR of 6% during the forecast period. The high prevalence of gastric cancer in the United States, as well as increasing research and development investment have contributed to the large market in the country.
United kingdom Gastro-retentive Drug Delivery Systems Market Analysis
The market in the United kingdom is expected to reach a valuation of US$ 1 Billion by 2033. Growing with a CAGR of 6.1% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around US$ 400 Million.
Japan Gastro-retentive Drug Delivery Systems Market Analysis
In Japan, the market is expected to grow at a CAGR of 7.2% from 2023 to 2033, reaching around US$ 1 Billion by 2033. The market in the country is expected to gross an absolute dollar opportunity of US$ 500 Million during the forecast period.
South Korea Gastro-retentive Drug Delivery Systems Market Analysis
The market in South Korea is expected to reach a valuation of around US$ 700 Million by 2033, growing at a CAGR of 7.3% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around US$ 400 Million.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
Which Type of Gastro-retentive Drug Delivery System will be most preferred?
Floating Drug Delivery systems are expected to account for significant market revenue and are expected to grow at a CAGR of 5% during the forecast period. Using floating medication delivery devices is one of the most important ways for improving stomach retention and drug bioavailability. Due to this, the system has a lower bulk density than gastric fluids, it may stay buoyant in the stomach for extended periods of time without interfering with the process of gastric emptying.
This mechanism gradually and at a predetermined rate delivers the drug. When medicine is administered, the stomach's residual system is emptied. This improves segmental development by lengthening stomach retention and better control over changes in plasma medicine concentration.
Competitive Analysis
Manufacturers will benefit from proprietary benefits such as industry research financing and product development agreements, which will help them contribute to the development of effective cancer diagnosis technologies. Obtaining patents and government clearances for new technology will also continue to be a key growth strategy.
The key players in the market include Ranbaxy, F. Hoffmann La Roche, Pharmacia, GlaxoSmithKline, Lupin, Pfizer, Depomed, Galanix, Sun Pharma, and Alcon, Inc.
Few of the recent developments of key Gastro-retentive Drug Delivery Systems providers are as follows:
In 2020, Cadila Pharmaceuticals launched Esomeprazole tablets which will be used in treatment of hyperacidity and drug induced gastritis.
In 2020, Xiromed LLC launched 20mg Omperazole delayed release capsules. Omeprazole is cost effective generic product which can be used in treatment of gastroesophageal reflux disease and healing of erosive esophagitis.
Similarly, recent developments related to companies offering Gastro-retentive Drug Delivery Systems have been tracked by the team at Future Market Insights, which are available in the full report.
Market Segments Covered in Gastro-retentive Drug Delivery Systems Industry Analysis
By Type:
High Density System
Expandable Drug Delivery System
Bioadhesive Drug Delivery System
Floating Drug Delivery System
Others
By Dosage Form:
Tablets
Liquid
Microspheres
Capsule
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
Latin America
Europe
APAC
MEA
Frequently Asked Questions
How Big is the Gastro-retentive Drug Delivery Systems Market?
The market is expected to attain a value of US$ 14 billion in 2023.
Which Factors are Driving the Market Growth?
Large drug firms' investments and technological advancements are driving the market growth.
Which Region is Expected to Offer Significant Opportunity for Gastro-retentive Drug Delivery Systems?
North America is expected to offer significant opportunity for gastro-retentive drug delivery systems.
Which Product Type is Highly Preferred in the Market?
Floating drug delivery systems are highly preferred in the market.
What is South Korea’s Market Growth Outlook?
The South Korea market is expected to expand at a CAGR of 7.3%.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type , 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type , 2023 to 2033
5.3.1. High Density System
5.3.2. Expandable Drug Delivery System
5.3.3. Bioadhesive Drug Delivery System
5.3.4. Floating Drug Delivery System
5.3.5. Other Types
5.4. Y-o-Y Growth Trend Analysis By Type , 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type , 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Dosage Form
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Dosage Form, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Dosage Form, 2023 to 2033
6.3.1. Tablets
6.3.2. Liquid
6.3.3. Microspheres
6.3.4. Capsule
6.3.5. Other Dosage Forms
6.4. Y-o-Y Growth Trend Analysis By Dosage Form, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Dosage Form, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Type
9.2.3. By Dosage Form
9.2.4. By Distribution Channel
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.3.3. By Dosage Form
9.3.4. By Distribution Channel
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Type
10.2.3. By Dosage Form
10.2.4. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By Dosage Form
10.3.4. By Distribution Channel
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. United kingdom
11.2.1.5. Russia
11.2.1.6. BENELUX
11.2.1.7. Rest of Europe
11.2.2. By Type
11.2.3. By Dosage Form
11.2.4. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By Dosage Form
11.3.4. By Distribution Channel
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Rest of Asia Pacific
12.2.2. By Type
12.2.3. By Dosage Form
12.2.4. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By Dosage Form
12.3.4. By Distribution Channel
12.4. Key Takeaways
13. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Turkey
13.2.1.4. Rest of Middle East and Africa
13.2.2. By Type
13.2.3. By Dosage Form
13.2.4. By Distribution Channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By Dosage Form
13.3.4. By Distribution Channel
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Type
14.1.2.2. By Dosage Form
14.1.2.3. By Distribution Channel
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Type
14.2.2.2. By Dosage Form
14.2.2.3. By Distribution Channel
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Type
14.3.2.2. By Dosage Form
14.3.2.3. By Distribution Channel
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Type
14.4.2.2. By Dosage Form
14.4.2.3. By Distribution Channel
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Type
14.5.2.2. By Dosage Form
14.5.2.3. By Distribution Channel
14.6. Italy
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Type
14.6.2.2. By Dosage Form
14.6.2.3. By Distribution Channel
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Type
14.7.2.2. By Dosage Form
14.7.2.3. By Distribution Channel
14.8. United kingdom
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Type
14.8.2.2. By Dosage Form
14.8.2.3. By Distribution Channel
14.9. Russia
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Type
14.9.2.2. By Dosage Form
14.9.2.3. By Distribution Channel
14.10. BENELUX
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Type
14.10.2.2. By Dosage Form
14.10.2.3. By Distribution Channel
14.11. China
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Type
14.11.2.2. By Dosage Form
14.11.2.3. By Distribution Channel
14.12. Japan
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Type
14.12.2.2. By Dosage Form
14.12.2.3. By Distribution Channel
14.13. South Korea
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Type
14.13.2.2. By Dosage Form
14.13.2.3. By Distribution Channel
14.14. GCC Countries
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Type
14.14.2.2. By Dosage Form
14.14.2.3. By Distribution Channel
14.15. South Africa
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By Type
14.15.2.2. By Dosage Form
14.15.2.3. By Distribution Channel
14.16. Turkey
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2022
14.16.2.1. By Type
14.16.2.2. By Dosage Form
14.16.2.3. By Distribution Channel
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Type
15.3.3. By Dosage Form
15.3.4. By Distribution Channel
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. F. Hoffmann La Roche
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Ranbaxy
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. GlaxoSmithKline
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Pharmacia
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Depomed
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Alcon, Inc.
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Lupin
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Galanix
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Sun Pharma
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
17. Assumptions & Acronyms Used18. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 4: Global Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 7: North America Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 8: North America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 10: Latin America Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 11: Latin America Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 12: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Europe Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 15: Europe Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 16: Europe Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
Table 17: Asia Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 18: Asia Pacific Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 19: Asia Pacific Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 20: Asia Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
Table 21: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 24: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Type, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Distribution Channel, 2023 to 2033
Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 9: Global Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 10: Global Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 11: Global Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 12: Global Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 13: Global Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 14: Global Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033
Figure 15: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 16: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 17: Global Market Attractiveness by Type, 2023 to 2033
Figure 18: Global Market Attractiveness by Dosage Form, 2023 to 2033
Figure 19: Global Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 20: Global Market Attractiveness by Region, 2023 to 2033
Figure 21: North America Market Value (US$ Million) by Type, 2023 to 2033
Figure 22: North America Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 23: North America Market Value (US$ Million) by Distribution Channel, 2023 to 2033
Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 28: North America Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 29: North America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 30: North America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 31: North America Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 34: North America Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 37: North America Market Attractiveness by Type, 2023 to 2033
Figure 38: North America Market Attractiveness by Dosage Form, 2023 to 2033
Figure 39: North America Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 40: North America Market Attractiveness by Country, 2023 to 2033
Figure 41: Latin America Market Value (US$ Million) by Type, 2023 to 2033
Figure 42: Latin America Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 43: Latin America Market Value (US$ Million) by Distribution Channel, 2023 to 2033
Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 48: Latin America Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 51: Latin America Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 54: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 57: Latin America Market Attractiveness by Type, 2023 to 2033
Figure 58: Latin America Market Attractiveness by Dosage Form, 2023 to 2033
Figure 59: Latin America Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 61: Europe Market Value (US$ Million) by Type, 2023 to 2033
Figure 62: Europe Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 63: Europe Market Value (US$ Million) by Distribution Channel, 2023 to 2033
Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 68: Europe Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 69: Europe Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 71: Europe Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 72: Europe Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 74: Europe Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033
Figure 75: Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 76: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 77: Europe Market Attractiveness by Type, 2023 to 2033
Figure 78: Europe Market Attractiveness by Dosage Form, 2023 to 2033
Figure 79: Europe Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 80: Europe Market Attractiveness by Country, 2023 to 2033
Figure 81: Asia Pacific Market Value (US$ Million) by Type, 2023 to 2033
Figure 82: Asia Pacific Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 83: Asia Pacific Market Value (US$ Million) by Distribution Channel, 2023 to 2033
Figure 84: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 85: Asia Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 88: Asia Pacific Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 91: Asia Pacific Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 94: Asia Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033
Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 97: Asia Pacific Market Attractiveness by Type, 2023 to 2033
Figure 98: Asia Pacific Market Attractiveness by Dosage Form, 2023 to 2033
Figure 99: Asia Pacific Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 100: Asia Pacific Market Attractiveness by Country, 2023 to 2033
Figure 101: Middle East and Africa Market Value (US$ Million) by Type, 2023 to 2033
Figure 102: Middle East and Africa Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 103: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2023 to 2033
Figure 104: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033
Figure 105: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 106: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 107: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 108: Middle East and Africa Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 109: Middle East and Africa Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 110: Middle East and Africa Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 111: Middle East and Africa Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 112: Middle East and Africa Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 113: Middle East and Africa Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 114: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033
Figure 115: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033
Figure 116: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033
Figure 117: Middle East and Africa Market Attractiveness by Type, 2023 to 2033
Figure 118: Middle East and Africa Market Attractiveness by Dosage Form, 2023 to 2033
Figure 119: Middle East and Africa Market Attractiveness by Distribution Channel, 2023 to 2033
Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
